This hypothesis is significantly bolstered by research linking brain insulin resistance in humans to reduced arterial blood flow and cerebral perfusion [78], increased risk of cerebrovascular disease [79], and decreased vascular insulin receptor concentrations observed in the parietal cortex of AD patients [80]. The gene discussed is INSR; the disease is Alzheimer disease.